Asepticys Overview

  • Founded
  • 2015

  • Status
  • Out of Business

  • Employees
  • 3

  • Latest Deal Type
  • Out of Business

Asepticys General Information


Developer of infection protection drugs designed to shield from hidden microbial threats. The company's drugs combat skin and wound infections caused by protozoa, bacteria, fungi, and viruses and are safe for use on human skin, eyes and tissue, enabling patients to use the medicine on their skin, eyes, and tissue and protect their health.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 204 South Union Street
  • Alexandria, VA 22314
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asepticys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 18-Mar-2021 000.00 Completed Out of Business
4. Early Stage VC (Series A1) 28-Nov-2018 000 000.00 Completed Clinical Trials - General
3. Early Stage VC (Series A1) 16-Apr-2018 00.000 00.000 Completed Clinical Trials - General
2. Early Stage VC 29-Nov-2016 $2M $3.58M Completed Startup
1. Early Stage VC (Series A) 08-Mar-2016 $1.57M $1.57M 0000 Completed Startup
To view Asepticys’s complete valuation and funding history, request access »

Asepticys Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Asepticys’s complete cap table history, request access »

Asepticys Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial